Literature DB >> 32287580

Chapter 7 Orthomyxovirus infections.

.   

Abstract

The earth is a unity for influenza A virus in a manner not yet found for probably any other parasite and epidemics occur in all inhabited parts of the globe regardless of latitude, longitude, altitude, climate, rainfall, temperature, humidity, race and sex. Influenza A is the classic pandemic virus infection of man and influenza B virus also can cause sharp outbreaks, resulting in significant mortality. An overwhelming amount of data has accumulated on the biochemistry, cell biology, and epidemiology of influenza, but prospects of control of epidemics in the near future are dim. Meanwhile, a holding operation can be achieved using inactivated vaccine and rimantadine (100 mg/daily) in special risk groups in the population until new more effective vaccines and broad spectrum antivirals (active against influenza A and B virus) are developed. Research work is centered on biotechnology to produce immunogenic peptides and proteins and more logical searches for antivirals using amino acid sequence data and also virus specific enzymes such as the virion transcriptase as targets. © 1985.

Entities:  

Year:  2008        PMID: 32287580      PMCID: PMC7134264          DOI: 10.1016/S0168-7069(08)70015-6

Source DB:  PubMed          Journal:  Perspect Med Virol        ISSN: 0168-7069


  143 in total

1.  Effect of 5'-terminal structure and base composition on polyribonucleotide binding to ribosomes.

Authors:  G W Both; Y Furuichi; S Muthukrishnan; A J Shatkin
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

2.  Administration of amantadine for the prevention of Hong Kong influenza.

Authors:  I Nafta; A G TTurcanu; I Braun; W Companetz; A Simionescu; E Birţ; V Florea
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

3.  Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.

Authors:  H Heider; B Adamczyk; H W Presber; C Schroeder; R Feldblum; M K Indulen
Journal:  Acta Virol       Date:  1981-11       Impact factor: 1.162

Review 4.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

5.  Consensus on amantadine use in influenza A.

Authors:  J Elliott
Journal:  JAMA       Date:  1979-11-30       Impact factor: 56.272

6.  Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.

Authors:  A S Beare; G C Schild; J W Craig
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

7.  Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins.

Authors:  S M Carroll; H H Higa; J C Paulson
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

8.  Complete nucleotide sequence of an influenza virus haemagglutinin gene from cloned DNA.

Authors:  A G Porter; C Barber; N H Carey; R A Hallewell; G Threlfall; J S Emtage
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

9.  Influenza vaccination.

Authors:  M A Riddiough; J E Sisk; J C Bell
Journal:  JAMA       Date:  1983-06-17       Impact factor: 56.272

10.  New opportunities for development of safe, effective live virus vaccines.

Authors:  R M Chanock
Journal:  Yale J Biol Med       Date:  1982 May-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.